Mitochondria and the neurotoxicity of MPTP
- 31 December 1986
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 7, 473-475
- https://doi.org/10.1016/0165-6147(86)90426-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Mechanism of MPTP toxicity: more answers, more questionsTrends in Pharmacological Sciences, 1985
- MPTP and parkinson's diseaseTrends in Neurosciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Destroys Dopamine Neurons in Explants of Rat Embryo MesencephalonScience, 1984
- High-affinity binding sites for [3H]MPTP may correspond to monamine oxidaseEuropean Journal of Pharmacology, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979